Elanco gets U.S. regulatory approval for $7.6B Bayer acquisition

Please subscribe to IBJ to decode this article.

eIsa,rsayrrraaE a eCde7t eeovfp.ye erail ubosto lnldi dmeTin imiqBS6a ueo Fn.mG va BAdi fdrbiAamdnma tmltu aei ahn oectorW e c er fillonsue a lvfnnahoanoigeisnecAid$nmttantd oHrei.o siepe cannn.Glhuoghayi ccGsfi .nysdnaaUlmspntd onol aHriahe-ho r

ottr eecTa pesie h namthtctutneseeo ldc Fhlanaidls iaotd.tertec cnsCe ininfn oiae Tr

trmdstaowcmcget’ ,r hclnEdoheiehsihuof-i2L lsws e silt au, l uol0 h.y-eobApuEoaJotwrfecdcocoeNae rse eh8on t- naC oltau , gc dh1.p ealbsn t ti oimhs fne weoaanht a nnmasl yeslqrlsc onyisayentanoso gae idhulirdoefrilntsuhladi f t T. likrrdiEZp

v,nrseae2 fa ash t on%Eorys oaoca4ero.in.shdp tgmel3hn.rWuaSdi8o tnaeenla$c d p 2earn cew1 n

feh,fs oti d0Getn,sanhaile ill 100cnwirahileh,e0d,oeenals en.r00d di2 1em83sdlgr.nccuawy h abo hop Toi5o9 n rmo$ iepe wm h lnmy

ni4 lu pdvtie rnhiuno$ool0ptnlorr cn$lioc0ie2oo .tnni gd hErnrvu l sl i a eo vehveacyeeltnstagf1e u 1 aieter amnmdueseoao vw esitlre yfe

eenniir, o na ai r in so roritc,u nccdnpbaau.Cefmsi hl SivuoadCearnhdnne eCspuatlri.catnttraoeros,Erraahrfr ycevonUminTaana aeiiVntr avoe,lt ,o c eel i i, i BacEaokllthkcu,epA aazs,

pth.tt nclioo s dEkititpsrslhvcucosdlsid,cloaogdac tisedtu lb rcatnna l-eeaenrnugpelnosin

sphni dtd iwia gpniio of”eoroe icstkatAitnea neomiE dfpaiy tl n.oeet i maniadehoo pm cenoop ,I oene eger gm dt l intahksgndhiaicdCipealnrna ,gm wllEg bsoaeroth rax lmaoedotrvleJg n ali ons iieocpirnwts o oo rmlwec rrinhsironato Odoonagtaokmnd id r,a”inso no tgf cnosr,,sstst n, ofauiegdwlufy n nwnuuodui c fastervapspu etaoboosan lpat sftreet to arnt ir rrrcodf usnvnircnlltia p-ennesiatnniiesonhhd vrwhhoiln iphSndrgikaae tioanllnswttin rasrafltteestelyTn eeeegpe lt ek“isn.svfe“vl enceaosheth nadru asfalnr asoi